CoChat
Sign Up
Cited by 25

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

CETP polymorphisms influence cholesterol metabolism but not Alzheimer's disease risk

Qureischie, Homeira, Heun, Reinhard, Lütjohann, Dieter, Popp, Julius, Jessen, Frank, Ledschbor-Frahnert, Christine, Thiele, Holger, Maier, Wolfgang, Hentschel, Frank, Kelemen, Peter, Kölsch, Heike·2008·Brain Research
DOI 10.1016/j.brainres.2008.07.047
Open this paper in CoChat — free account

Abstract

Cholesteryl ester transfer protein (CETP) is a component of the high density lipoprotein (HDL). Variations in the CETP gene may cause CETP deficiency, which is characterized by decreased mass and activity of the protein as well as altered HDL and LDL levels. We investigated the effect of three putative functional CETP polymorphisms (-1946 VNTR, C-629A and I405V) on the risk of Alzheimer's disease (AD) and on cholesterol, lathosterol and 24S-hydroxycholesterol levels in CSF and plasma of AD patients and controls. None of the investigated CETP polymorphisms or haplotypes had any effect on the risk of AD. However, we found that a three marker CETP haplotype (L/C/V) influenced CSF levels of lathosterol and 24S-hydroxycholesterol as well as plasma levels of total cholesterol in controls but not in AD patients. Our data suggest that CETP gene variations influence cerebral and peripheral cholesterol metabolism, but not AD risk.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.brainres.2008.07.047

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 39

  1. Arias-Vasquez, 2007, The cholesteryl ester transfer protein (CETP) gene and the risk of Alzheimer's disease, Neurogenetics, 8, 189, 10.1007/s10048-007-0089-x · DOI
  2. Barzilai, 2006, A genotype of exceptional longevity is associated with preservation of cognitive function, Neurology, 67, 2170, 10.1212/01.wnl.0000249116.50854.65 · DOI
  3. Becker, 2004, A powerful strategy to account for multiple testing in the context of haplotype analysis, Am. J. Hum. Genet., 75, 561, 10.1086/424390 · DOI
  4. Becker, 2004, Maximum-likelihood estimation of haplotype frequencies in nuclear families, Genet. Epidemiol., 27, 21, 10.1002/gepi.10323 · DOI
  5. Björkhem, 2004, Brain cholesterol: long secret life behind a barrier, Atheroscler. Thromb. Vasc. Biol., 24, 806, 10.1161/01.ATV.0000120374.59826.1b · DOI · Paper page
  6. Borggreve, 2005, The effect of cholesteryl ester transfer protein -629 C→A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides, J. Clin. Endocrinol. Metab., 90, 4198, 10.1210/jc.2005-0182 · DOI
  7. Bretillon, 2000, Plasma levels of 24S-hydroxycholesterol in patients with neurological diseases, Neurosci. Lett., 293, 87, 10.1016/S0304-3940(00)01466-X · DOI
  8. Bruce, 1998, Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia, J. Lipid Res., 39, 1071, 10.1016/S0022-2275(20)33876-1 · DOI
  9. Chen, 2008, Cholesteryl ester transfer protein polymorphism D442G associated with a potential decreased risk of Alzheimer's disease as a modifier for APOE4 in Chinese, Brain Res., 1187, 52, 10.1016/j.brainres.2007.10.054 · DOI
  10. Dachet, 2000, New functional promoter polymorphism, CETP/ -629, in cholesteryl ester transfer protein (CETP) gene related to CETP mass and high density lipoprotein cholesterol levels (role of SP1/Sp3 in transcriptional regulation), Aterioscler. Thromb. Vasc. Biol., 20, 507, 10.1161/01.ATV.20.2.507 · DOI
  11. Dupuy, 2001, The relationship between apolipoprotein E4 and lipid metabolism is impaired in Alzheimer's disease, Gerontology, 47, 213, 10.1159/000052801 · DOI
  12. Fidani, 2004, An association study of the cholesteryl ester transfer protein TaqI B polymorphism with late onset Alzheimer's disease, Neurosci. Lett., 357, 152, 10.1016/j.neulet.2003.11.071 · DOI
  13. Folstein, 1975, “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician, J. Psychiatr. Res., 12, 189, 10.1016/0022-3956(75)90026-6 · DOI · Paper page
  14. Frisdal, 2005, Functional interaction between -629C/A, -971G/A and -1337C/T polymorphisms in the CETP gene is a major determinant of promoter activity and plasma CETP, Hum. Mol. Genet., 14, 2607, 10.1093/hmg/ddi291 · DOI
  15. Hamilton, 2007, Candidate gene association study of insulin signalling genes and Alzheimer's disease: evidence for SOS2, PCK1, and PPARgamma as susceptibility loci, Am. J. Med. Genet. B Neuropsychiatr. Genet., 144, 508, 10.1002/ajmg.b.30503 · DOI
  16. Heverin, 2004, Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease, J. Lipid Res., 45, 186, 10.1194/jlr.M300320-JLR200 · DOI
  17. Hixson, 1990, Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI, J. Lipid Res., 31, 545, 10.1016/S0022-2275(20)43176-1 · DOI · Paper page
  18. Jick, 2000, Statins and the risk of dementia, Lancet., 356, 1627, 10.1016/S0140-6736(00)03155-X · DOI
  19. Kivipelto, 2001, Midlife vascular risk factors and Alzheimer's Disease in later life: longitudinal, population based study, BMJ, 322, 1447, 10.1136/bmj.322.7300.1447 · DOI · Paper page
  20. Klerkx, 2003, Haplotype analysis of the CETP gene: not TaqIB, but the closely linked -629 C→A polymorphism and a novel promoter variant are independently associated with CETP concentration, Hum. Mol. Genet., 12, 111, 10.1093/hmg/ddg013 · DOI
  21. Kölsch, 2004, Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients, Neurosci. Lett., 368, 303, 10.1016/j.neulet.2004.07.031 · DOI
  22. Lira, 2004, Highly polymorphic repeat region in the CETP promoter induces unusual DNA structure, Biochim. Biophys. Acta, 1684, 38, 10.1016/j.bbalip.2004.06.002 · DOI
  23. Lütjohann, 1996, Cholesterol homeostasis in human brain: evidence for an age dependent flux of 24S-hydroxycholesterol from the brain into the circulation, Proc. Natl. Acad. Sci. USA, 93, 9799, 10.1073/pnas.93.18.9799 · DOI · Paper page
  24. Lütjohann, 2000, Plasma 24S-hydroxycholesterol (cerebrosterol) is increased in Alzheimer and vascular demented patients, J. Lipid Res., 41, 195, 10.1016/S0022-2275(20)32052-6 · DOI
  25. Montine, 1997, Central nervous system lipoproteins in Alzheimer's disease, Am. J. Pathol., 151, 1571
  26. Morozova, 2005, Cholesterol metabolism modulators in future drug therapy for atherosclerosis, Med. Sci. (Paris), 21, 53
  27. Mulder, 1998, Reduced levels of cholesterol, phospholipids, and fatty acids in cerebrospinal fluid of Alzheimer disease patients are not related to apolipoprotein E4, Alzheimer Dis. Assoc. Disord., 12, 198, 10.1097/00002093-199809000-00012 · DOI
  28. Notkola, 1998, Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease, Neuroepidemiol., 17, 14, 10.1159/000026149 · DOI
  29. Rodríguez, 2006, Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE4 allele, J. Neurol., 253, 181, 10.1007/s00415-005-0945-2 · DOI · Paper page
  30. Schaid, 2002, Score tests for association between traits and haplotypes when linkage phase is ambiguous, Am. J. Hum. Genet., 70, 425, 10.1086/338688 · DOI
  31. Schatz, 2001, Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study, Lancet, 358, 351, 10.1016/S0140-6736(01)05553-2 · DOI
  32. Strittmatter, 1993, Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer's disease, Proc. Natl. Acad. Sci. USA, 90, 8098, 10.1073/pnas.90.17.8098 · DOI · Paper page
  33. Talmud, 2000, Linkage of the cholesteryl ester transfer protein (CETP) gene to LDL particle size, Circulation, 101, 2461, 10.1161/01.CIR.101.21.2461 · DOI
  34. Tall, 1993, Plasma cholesteryl ester transfer protein, J. Lipid Res., 34, 1255, 10.1016/S0022-2275(20)36957-1 · DOI · Paper page
  35. Teunissen, 2003, Combination of serum markers related to several mechanisms in Alzheimer's disease, Neurobiol. Aging, 24, 893, 10.1016/S0197-4580(03)00005-8 · DOI
  36. Thompson, 2003, Polymorphisms in the CETP gene and association with CETP mass and HDL levels, Atherosclerosis, 167, 195, 10.1016/S0021-9150(03)00005-4 · DOI
  37. von Trotha, 2006, Influence of lysosomal acid lipase polymorphisms on chromosome 10 on the risk of Alzheimer's disease and cholesterol metabolism, Neurosci. Lett., 402, 262, 10.1016/j.neulet.2006.04.009 · DOI
  38. Wolozin, 2000, Decreased prevalence of Alzheimer's disease associated with 3-hydroxy-3methylglutaryl coenzyme A reductase inhibitors, Arch. Neurol., 57, 1439, 10.1001/archneur.57.10.1439 · DOI
  39. Zhu, 2005, Lack of genetic association of cholesteryl ester transfer protein polymorphisms with late onset Alzheimer's disease, Neurosci. Lett., 381, 36, 10.1016/j.neulet.2005.01.078 · DOI

Cited by

Sorted by citations

Metadata

Authors
Qureischie, H., Heun, R., Lütjohann, D., Popp, J., Jessen, F., Ledschbor-Frahnert, C., Thiele, H., Maier, W., Hentschel, F., Kelemen, P., & Kölsch, H.
Venue
Brain Research
Publisher
Elsevier BV
Published
2008-09
Volume
1232
Pages
1-6
ISSN
0006-8993
DOI
10.1016/j.brainres.2008.07.047
Cited by
25
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review